Author

E. M. Johnson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:fungi (other)· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. M. Borman· 2 shared J.-W. Suh· 2 shared A. Alghamdi· 1 shared A. C. Singer· 1 shared A. P. Brackin· 1 shared C. B. Uzzell· 1 shared D. Malavia-Jones· 1 shared F. B. Piel· 1 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. M. Borman

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Strain and temperature dependent aggregation of Candida auris is attenuated by inhibition of surface amyloid proteins

D. Malavia-Jones, R. A. Farrer, M. Stappers, M. B. Edmondson, A. M. Borman, E. M. Johnson, P. N. Lipke, N. A. R. Gow

This study investigates strain and temperature-dependent aggregation in Candida auris, finding that amyloid protein inhibition reduces aggregation without affecting cell separation.

bioRxiv · May 9, 2023 · PreprintMicrobiology

Synthesis of water-soluble and gastrointestinal transit-resistant FA-FOS conjugate for targeted delivery to the colon: pharmacokinetics, pharmacodynamics, efficacy

E. M. Johnson, J.-W. Suh

This paper synthesizes a water-soluble FA-FOS conjugate resistant to gastrointestinal transit, evaluates its pharmacokinetics, pharmacodynamics, and efficacy in delivering FA to the colon and tumors.

bioRxiv · May 5, 2023 · PreprintPharmacology & Toxicology

Anticancer, anti-inflammatory, and immune modulatory activity of ferulic acid fructo-oligosaccharide conjugated microparticle

E. M. Johnson, R. Jayabalan, S. Patra, J.-W. Suh

This study evaluates the anticancer, anti-inflammatory, and immune modulatory effects of ferulic acid fructo-oligosaccharide conjugated microparticles in vitro and in vivo.

bioRxiv · May 5, 2023 · PreprintCancer Biology

Landscape-scale exposure to multiazole-resistant Aspergillus fumigatus bioaerosols

J. M. G. Shelton, J. Rhodes, C. B. Uzzell, S. Hemmings, A. P. Brackin, T. R. Sewell, A. Alghamdi, P. S. Dyer, M. Fraser, A. M. Borman, E. M. Johnson, F. B. Piel, A. C. Singer, M. Fisher

UK-wide citizen science surveillance finds a ubiquitous exposure to aerosolized spores of a human fungal pathogen that have evolved cross-resistance to essential clinical antifungal drugs.

bioRxiv · Nov 7, 2022 · PreprintMicrobiology